Nagarkatti P - Search Results

1

Antibody blockade of CLEC12A delays EAE onset and attenuates disease severity by impairing myeloid cell CNS infiltration and restoring positive immunity.

Sagar D, Singh NP, Ginwala R, Huang X, Philip R, Nagarkatti M, Nagarkatti P, Neumann K, Ruland J, Andrews AM, Ramirez SH, Khan ZK, Jain P. Sagar D, et al. Among authors: nagarkatti p, nagarkatti m. Sci Rep. 2017 Jun 2;7(1):2707. doi: 10.1038/s41598-017-03027-x. Sci Rep. 2017. PMID: 28578388 Free PMC article.

2

Immunomodulatory properties of AZT.

McKallip RJ, Nagarkatti M, Nagarkatti P. McKallip RJ, et al. Among authors: nagarkatti p, nagarkatti m. Ann N Y Acad Sci. 1993 Jun 23;685:464-6. doi: 10.1111/j.1749-6632.1993.tb35907.x. Ann N Y Acad Sci. 1993. PMID: 8363254 No abstract available.

3

Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease.

McKallip RJ, Lombard C, Fisher M, Martin BR, Ryu S, Grant S, Nagarkatti PS, Nagarkatti M. McKallip RJ, et al. Blood. 2002 Jul 15;100(2):627-34. doi: 10.1182/blood-2002-01-0098. Blood. 2002. PMID: 12091357 Free article.

4

Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo.

McKallip RJ, Lombard C, Martin BR, Nagarkatti M, Nagarkatti PS. McKallip RJ, et al. J Pharmacol Exp Ther. 2002 Aug;302(2):451-65. doi: 10.1124/jpet.102.033506. J Pharmacol Exp Ther. 2002. PMID: 12130702

5

Analysis of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced gene expression profile in vivo using pathway-specific cDNA arrays.

Zeytun A, McKallip RJ, Fisher M, Camacho I, Nagarkatti M, Nagarkatti PS. Zeytun A, et al. Toxicology. 2002 Sep 16;178(3):241-60. doi: 10.1016/s0300-483x(02)00230-5. Toxicology. 2002. PMID: 12167310

6

Role of CD44 in activation-induced cell death: CD44-deficient mice exhibit enhanced T cell response to conventional and superantigens.

McKallip RJ, Do Y, Fisher MT, Robertson JL, Nagarkatti PS, Nagarkatti M. McKallip RJ, et al. Int Immunol. 2002 Sep;14(9):1015-26. doi: 10.1093/intimm/dxf068. Int Immunol. 2002. PMID: 12202399

7

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces Fas-dependent activation-induced cell death in superantigen-primed T cells.

Camacho IA, Nagarkatti M, Nagarkatti PS. Camacho IA, et al. Arch Toxicol. 2002 Oct;76(10):570-80. doi: 10.1007/s00204-002-0390-2. Epub 2002 Aug 6. Arch Toxicol. 2002. PMID: 12373453

8

Role of death receptor pathway in estradiol-induced T-cell apoptosis in vivo.

Do Y, Ryu S, Nagarkatti M, Nagarkatti PS. Do Y, et al. Toxicol Sci. 2002 Nov;70(1):63-72. doi: 10.1093/toxsci/70.1.63. Toxicol Sci. 2002. PMID: 12388836

9

Regulation of interleukin-2-induced vascular leak syndrome by targeting CD44 using hyaluronic acid and anti-CD44 antibodies.

Mustafa A, McKallip RJ, Fisher M, Duncan R, Nagarkatti PS, Nagarkatti M. Mustafa A, et al. J Immunother. 2002 Nov-Dec;25(6):476-88. doi: 10.1097/00002371-200211000-00004. J Immunother. 2002. PMID: 12439345

10

Targeted deletion of CD44v7 exon leads to decreased endothelial cell injury but not tumor cell killing mediated by interleukin-2-activated cytolytic lymphocytes.

McKallip RJ, Fisher M, Do Y, Szakal AK, Gunthert U, Nagarkatti PS, Nagarkatti M. McKallip RJ, et al. J Biol Chem. 2003 Oct 31;278(44):43818-30. doi: 10.1074/jbc.M304467200. Epub 2003 Aug 6. J Biol Chem. 2003. PMID: 12904302 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

353 results

Search Page